Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

about

Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B Case-control study and case series of pseudohyperphosphatemia during exposure to liposomal amphotericin B.Hyperphosphataemia: treatment options.

P2860

Q35526999-221D2C10-4214-4954-8B84-BF383289D983 Q36158204-205DD19C-E306-4340-B93E-C1F983173928 Q38102603-FD597879-DE91-4D29-A4CC-B5EDA0E516BC

P2860

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

Item

http://www.wikidata.org/entity/Q36248701

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

@ast

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

@en

type

Item

label

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

@ast

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

@en

prefLabel

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

@ast

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

@en

P1476

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

@en

P2093

Glen L Hortin

http://www.w3.org/2001/XMLSchema#string

Jason W Lane

http://www.w3.org/2001/XMLSchema#string

Nadja N Rehak

http://www.w3.org/2001/XMLSchema#string

Philip R Krause

http://www.w3.org/2001/XMLSchema#string

Theoklis Zaoutis

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.

Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.

Acute hyperphosphatemia caused by sodium phosphate enema in a patient with liver dysfunction and chronic renal failure.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.

AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience.

The acidosis of exogenous phosphate intoxication.

Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients

Review of the literature: severe hyperphosphatemia.

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.

P304

145-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCA.2007.08.008

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

387

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5908184

http://www.w3.org/2001/XMLSchema#string

P698

17936740

http://www.w3.org/2001/XMLSchema#string

P932

2128727

http://www.w3.org/2001/XMLSchema#string

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

about

P2860

P2860

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932